Luise Brenner, die Mutter von Assistenzarzt Hans-Peter Brenner, kommt mit diffusen Oberbauchbeschwerden in die Klinik.

Background: Malignant Brenner tumor (MBT) is a rare and aggressive subtype of ovarian cancer, accounting for less than 1-2% of all ovarian malignancies. Despite its rarity, MBT carries a high ...

Researchers have developed a drug shown to significantly extend survival time for patients with glioblastoma, the most common primary brain tumor in adults, according to results of a new trial.

Brenner, who also is clinical investigator for the Institute for Drug Development at UT Health San Antonio and co-leader of its Experimental and Development Therapeutics Program, is lead author of ...

Dr. Malcolm Brenner and Dr. Cliona Rooney of Baylor College of Medicine are two of the 170 academic inventors named ... She has developed and clinically evaluated strategies that render T cells ...

The MRI shows a brain tumor in an inauspicious location, and a brain biopsy will entail high risks for a patient who had consulted doctors due to double vision. Situations such as this case ...

A pioneering biobattery has been shown to reduce tumor growth in the body and could hold the key to a new drug-free immunotherapy treatment in cancer patients. Biobatteries have the same basic ...

The 46 primary-tumor regions from 21 patients with CHIP had a higher representation of myeloid cells than the 117 tumor regions from 49 patients without CHIP (age-adjusted odds ratio, 1.20; 95% CI ...